https://scholars.lib.ntu.edu.tw/handle/123456789/586864| Title: | New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies | Authors: | Tsai, Cheng-Hsuan Chen, Ya-Li Pan, Chien-Ting Lin, Yen-Tin Lee, Po-Chin Chiu, Yu-Wei Liao, Che-Wei Chen, Zheng-Wei CHIN-CHEN CHANG Chang, Yi-Yao Hung, Chi-Sheng Lin, Yen-Hung |
Keywords: | adrenalectomy; atrial fibrillation; hyperaldosteronism; mineralocorticoid receptor antagonist; primary aldosteronism;adrenalectomy; atrial fibrillation; hyperaldosteronism; mineralocorticoid receptor antagonist; primary aldosteronism | Issue Date: | 2021 | Journal Volume: | 12 | Source: | Frontiers in endocrinology | Abstract: | Primary aldosteronism (PA) is a common cause of secondary hypertension and associated with higher incidence of new-onset atrial fibrillation (NOAF). However, the effects of surgical or medical therapies on preventing NOAF in PA patents remain unclear. The aim of this meta-analysis study was to assess the risk of NOAF among PA patients receiving mineralocorticoid receptor antagonist (MRA) treatment, PA patients receiving adrenalectomy, and patients with essential hypertension. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/586864 | ISSN: | 1664-2392 | DOI: | 10.3389/fendo.2021.646933 | metadata.dc.subject.other: | mineralocorticoid antagonist; adrenalectomy; cerebrovascular accident; congestive heart failure; essential hypertension; follow up; heart arrhythmia; heart infarction; human; hyperthyroidism; incidence; meta analysis; mitral valve disease; new-onset atrial fibrillation; observational study; primary hyperaldosteronism; prospective study; randomized controlled trial (topic); retrospective study; Review; risk factor; systematic review [SDGs]SDG3 |
| Appears in Collections: | 法醫學科所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.